<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Vidarabine</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Vidarabine">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Vidarabine</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Vidarabine</b> or <b>9-Î²-D-arabinofuranosyladenine (ara-A)</b> is an antiviral drug which is active against herpes simplex and varicella zoster viruses.</p>

<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Vidarabine</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Vidarabine.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Vidarabine.svg.png" data-file-width="512" data-file-height="493" data-file-type="drawing" height="144" width="150"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/cons/vidarabine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/cons/vidarabine.html'" tppabs="https://www.drugs.com/cons/vidarabine.html" class="external text external">Micromedex Detailed Consumer Information</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>J05AB03<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=J05AB03  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=J05AB03'" tppabs="https://www.whocc.no/atc_ddd_index/?code=J05AB03" class="external text external">WHO</a></span>)<span> </span>S01AD06<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=S01AD06  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=S01AD06'" tppabs="https://www.whocc.no/atc_ddd_index/?code=S01AD06" class="external text external">WHO</a></span>)</li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>24-38%</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(2<i>R</i>,3<i>S</i>,4<i>S</i>,5<i>R</i>)-2-(6-Amino-9<i>H</i>-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol hydrate</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=24356-66-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=24356-66-9'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=24356-66-9" class="external text external">24356-66-9</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/21704  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/21704'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/21704" class="external text external">21704</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4806  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4806'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4806" class="external text external">4806</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/D06298  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/D06298'" tppabs="https://www.drugbank.ca/drugs/D06298" class="external text external">D06298</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.20400.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.20400.html'" tppabs="http://www.chemspider.com/Chemical-Structure.20400.html" class="external text external">20400</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=3XQD2MEW34  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=3XQD2MEW34'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=3XQD2MEW34" class="external text external">3XQD2MEW34</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D00406  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D00406'" tppabs="https://www.kegg.jp/entry/D00406" class="external text external">D00406</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1090  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1090'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1090" class="external text external">ChEMBL1090</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">NIAID ChemDB</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=007328  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=007328'" tppabs="https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=007328" class="external text external">007328</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID80873976  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID80873976'" tppabs="https://comptox.epa.gov/dashboard/DTXSID80873976" class="external text external">DTXSID80873976</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.024.449  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.024.449'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.024.449" class="external text external">100.024.449</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>10</sub><span>H</span><sub>13</sub><span>N</span><sub>5</sub><span>O</span><sub>4</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">267.245</span><span>&nbsp;</span>gÂ·mol<sup>â1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=C1%3DNC%28%3DC2C%28%3DN1%29N%28C%3DN2%29%5BC%40H%5D3%5BC%40H%5D%28%5BC%40%40H%5D%28%5BC%40H%5D%28O3%29CO%29O%29O%29N  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=C1%3DNC%28%3DC2C%28%3DN1%29N%28C%3DN2%29%5BC%40H%5D3%5BC%40H%5D%28%5BC%40%40H%5D%28%5BC%40H%5D%28O3%29CO%29O%29O%29N'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=C1%3DNC%28%3DC2C%28%3DN1%29N%28C%3DN2%29%5BC%40H%5D3%5BC%40H%5D%28%5BC%40%40H%5D%28%5BC%40H%5D%28O3%29CO%29O%29O%29N" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7+,10-/m1/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:OIRDTQYFTABQOQ-UHTZMRCNSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461752813&page2=Vidarabine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461752813&page2=Vidarabine'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461752813&page2=Vidarabine" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Discovery">Discovery</h2></summary>
    

<p>In the 1950s two nucleosides were isolated from the Caribbean sponge <i>Tethya crypta</i>: spongothymidine and spongouridine; which contained D-arabinose rather than <a href="Ribose.htm" tppabs="https://ptable.com/wiki/compounds/A/D-ribose" title="D-ribose" class="mw-redirect">D-ribose</a>. These compounds led to the synthesis of a new generation, sugar modified nucleoside analog vidarabine, and the related compound <a href="Cytarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cytarabine" title="Cytarabine">cytarabine</a>. In 2004 these were the only marine related compounds in clinical use.<span class="mw-ref" id="cite_ref-1"><a href="#cite_note-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>

<p>The drug was first synthesized in 1960 in the <span class="new">Bernard Randall Baker</span> lab at the Stanford Research Institute (now SRI International).<span class="mw-ref" id="cite_ref-Sneader_2-0"><a href="#cite_note-Sneader-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>The drug was originally intended as an anti-cancer drug.<span class="mw-ref" id="cite_ref-Sneader_2-1"><a href="#cite_note-Sneader-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span>  The anti-viral activity of vidarabine was first described by M. Privat de Garilhe and J. De Rudder in 1964.<span class="mw-ref" id="cite_ref-field_3-0"><a href="#cite_note-field-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span>  It was the first nucleoside analog antiviral to be given systemically and was the first agent to be licensed for the treatment of systematic herpes virus infection in humans.<span class="mw-ref" id="cite_ref-white_4-0"><a href="#cite_note-white-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It was University of Alabama at Birmingham researcher and physician <span class="new">Richard J. Whitley</span> in 1976 where the clinical effectiveness of vidarabine was first realized, and vidarabine was used in the treatment of many viral diseases.<span class="mw-ref" id="cite_ref-field_3-1"><a href="#cite_note-field-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>Vidarabine is an analog of adenosine with the D-ribose replaced with D-arabinose. As you can see from figure 1.1 that it is a stereoisomer of adenosine.
It has a half-life of 60 minutes, and its solubility is 0.05%, and is able to cross the bloodâbrain barrier (BBB) when converted to its active metabolite.<span class="mw-ref" id="cite_ref-waterson_5-0"><a href="#cite_note-waterson-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mode_of_action">Mode of action</h2></summary>
    

<p><figure-inline><img src="../I/m/Mechanism_of_action_of_vidarabine.gif" tppabs="https://ptable.com/wiki/compounds/I/m/Mechanism_of_action_of_vidarabine.gif" data-file-width="949" data-file-height="476" data-file-type="bitmap" height="291" width="580"></figure-inline></p>

<p><i>The Mechanism of action of vidarabine</i></p>

<p>Vidarabine works by interfering with the synthesis of viral DNA.<span class="mw-ref" id="cite_ref-mm_6-0"><a href="#cite_note-mm-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> It is a nucleoside analog and therefore has to be phosphorylated to be active. This is a three-step process in which vidarabine is sequentially phosphorylated by kinases to the triphosphate ara-ATP. This is the active form of vidarabine and is both an inhibitor and a substrate of viral DNA polymerase.<span class="mw-ref" id="cite_ref-mcguigan_7-0"><a href="#cite_note-mcguigan-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span>
When used as a substrate for viral DNA polymerase, ara-ATP competitively inhibits dATP leading to the formation of âfaultyâ DNA. This is where ara-ATP is incorporated into the DNA strand replacing many of the adenosine bases. This results in the prevention of DNA synthesis, as phosphodiester bridges can no longer to be built, destabilizing the strand.
Vidarabine triphosphate (ara-ATP) also inhibits RNA polyadenylation; preventing polyadenylation essential for HIV-1 and other retroviruses; and S-adenosylhomocysteine hydrolase, preventing transmethylation reactions.
Uniquely to vidarabine, the diphosphorylated vidarabine (ara-ADP) also has an inhibitory effect. Other nucleoside analogs need to be triphosphorlated to give any antiviral effect, but ara-ADP inhibits the enzyme ribonucleotide reductase. This prevents the reduction of nucleotide diphosphates, causing a reduction of viral replication.<span class="mw-ref" id="cite_ref-mcguigan_7-1"><a href="#cite_note-mcguigan-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mode_of_resistance">Mode of resistance</h2></summary>
    

<p>Vidarabine is more toxic and less metabolically stable than many of the other current antivirals such as <a href="Aciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Acyclovir" title="Acyclovir" class="mw-redirect">acyclovir</a> and <a href="Ganciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ganciclovir" title="Ganciclovir">ganciclovir</a>. Viral strains resistant to vidarabine show changes in DNA polymerase. It is prone to deamination by adenosine deaminase to <a href="Inosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Inosine" title="Inosine">inosine</a>.<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> This metabolite still possesses antiviral activity, but is 10-fold less potent than vidarabine.<span class="mw-ref" id="cite_ref-bmmc_9-0"><a href="#cite_note-bmmc-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> 60% of vidarabine eliminated by the kidney is excreted as 9-Î²-D-arabinofuranosylhypoxanthine in the urine. Some breakdown of the purine ring may also occur, forming uric acid.
Structural modifications of vidarabine have proven partially effective at blocking deamination, such as replacement of the amine with a methoxy group (ara-M). This results in about a 10-fold greater selectivity against Varicella Zoster Virus than ara-A, however analog of vidarabine is inactive against other viruses due to it not being able to be phosphorylated.<span class="mw-ref" id="cite_ref-bmmc_9-1"><a href="#cite_note-bmmc-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span>
The use of an inhibitor of adenosine deaminase to increase the half-life of vidarabine has also been tried, and drugs such as dCF and EHNA have been used with a small amount of success.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Synthesis,_preparation_and_isolation">Synthesis, preparation and isolation</h2></summary>
    

<p>Chemical synthesis of Vidarabine was first attained in 1960, as a part of studies on developing potential anticancer agents by B. R. Baker et al.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> based on unique biological properties of 1-Î²-D-arabinofuranosyluracil (ara-U).<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> More specifically some of its important reactions include treatments with 2'-deoxyribonucleoside phosphorylase, methyltransferase, or nucleoside phosphorylase, affording the corresponding 5'-phosphate, giving rise to no methylation at its 5-position, or no cleavage of the glycosyl bond in contrast to 5-fluoro-2'-deoxyuridine,<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> respectively. This earlier work gave impetus to further synthetic studies on the nucleosides with the Î²-D-arabinofuranosyl moiety including Vidarabine,<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> and the isolation of Vidarabine from the fermentation culture broth of Streptomyces antibioticus.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>

<p>In addition to the potential anticancer properties antiviral activity of Vidarabine was also demonstrated in 1965.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span>   Particularly worthy of mention is the collaboration of efficient chemical and enzymatic reactions, i.e., transesterification from ethylene carbonate to uridine accompanied by spontaneous intramolecular elimination of carbon dioxide giving 2,2'-O-anhydro-1-Î²-D-arabinofuranosyluracil (anhydro-ara-U);<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> and acid-hydrolysis of anhydro-ara-U giving ara-U; and subsequent enzymatic transglycosylation  of the sugar moiety of ara-U to the 9-position of adenine with perfect retention of the Î²-configuration.<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> and following papers.  Ultimately, in 1984, these pioneering syntheses led to the first commercial synthesis of Vidarabine in Japan under the trade name of "Arasena-A."   An enzymatic approach duplicating the same concept was also later reported.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span>
Furthermore, replacement of adenine with 2-fluoroadenine in the enzymatic transglycosylation reaction from ara-U to the 9-position of adenine made it bring about efficient synthesis of 2-fluoro-9-Î²-D-arabinofuranosyladenine (fludarabine).<span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Selectivity">Selectivity</h2></summary>
    

<p>Vidarabine is less susceptible to the development of drug resistant strains than other antivirals such as IDU, and has been used successfully in the treatment of IDU resistant viral strains.
The half-life of the active triphosphate metabolite (ara-ATP) is three times longer in HSV-infected cells compared with uninfected cells,<span class="mw-ref" id="cite_ref-bmmc_9-2"><a href="#cite_note-bmmc-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> however the mechanism of selectivity is not known.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Clinical_indication">Clinical indication</h2></summary>
    

<p>Vidarabine is an antiviral, active against herpes viruses, poxviruses, rhabdoviruses, hepadnaviruses and some RNA tumour viruses. A 3% ophthalmic ointment Vira-A is used in the treatment of acute keratoconjunctivitis and recurrent superficial keratitis caused by HSV-1 and HSV-2.<span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> Vidarabine is also used to treat herpes zoster in AIDS patients, reducing lesions formation and the duration of viral shedding.
Many of the previous uses of vidarabine have been superseded by <a href="Aciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Acyclovir" title="Acyclovir" class="mw-redirect">acyclovir</a>, due to the hospitalisation required for intra venous dosing, and acyclovir has a higher selectivity, lower inhibitory concentration and higher potency.
Toxic side effects are rare, but have been reported with high concentrations of vidarabine, such as nausea, vomiting, leukopenia and thrombocytopenia in patients receiving high intravenous doses daily.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-1"> <span id="mw-reference-text-cite_note-1" class="mw-reference-text">Kijjoa, A.; Sawangwong, P. Drugs and Cosmetics from the Sea. Mar. Drugs. 2004, 2, 73-82.</span></li><li id="cite_note-Sneader-2"> <span id="mw-reference-text-cite_note-Sneader-2" class="mw-reference-text"><cite id="CITEREFSneader,_Walter2005" class="citation book cs1">Sneader, Walter (2005). <i>Drug discovery: a history</i>. New York: Wiley. p.<span>&nbsp;</span>258. ISBN<span>&nbsp;</span><bdi>0-471-89979-8</bdi>.</cite></span></li><li id="cite_note-field-3"> <span id="mw-reference-text-cite_note-field-3" class="mw-reference-text">Field, H. J.; De Clercq, E. Antiviral Drugs â a short history of their discovery and development. Microbiology Today. 2004, 31, 58-61.</span></li><li id="cite_note-white-4"> <span id="mw-reference-text-cite_note-white-4" class="mw-reference-text">White, O. D.; Fenner, F. J. Medicinal Virology. 3rd Ed.</span></li><li id="cite_note-waterson-5"> <span id="mw-reference-text-cite_note-waterson-5" class="mw-reference-text">Waterson, A. P. Recent Advances in Clinical Virology (2).</span></li><li id="cite_note-mm-6"> <span id="mw-reference-text-cite_note-mm-6" class="mw-reference-text">Merck Manual. 17th Ed. Chapter 154, p.1127-1128.</span></li><li id="cite_note-mcguigan-7"> <span id="mw-reference-text-cite_note-mcguigan-7" class="mw-reference-text">McGuigan, C. Antiviral Chemotherapy â Cardiff University, 3rd Year Pharmacy Notes Lecture Notes.</span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text">Whitley, R. J.; Tucker, B. C.; Kinkel, A. W.; Barton, N. H.; Pass, R. F.; Whelchel, J. D.; Cobbs, C. G.; Diethelm, A. G.; Buchanan, R. A. Pharmacology, Tolerance, and Antiviral Activity of Vidarabine Monophosphate In Humans.</span></li><li id="cite_note-bmmc-9"> <span id="mw-reference-text-cite_note-bmmc-9" class="mw-reference-text">Burgers Medicinal Chemistry and Drug Discovery. 6th Ed.</span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text">Lee, W. W.; Benitez, A. Goodman, L.; Baker, B. R. Potential Anticancer Agents. XL. Synthesis of the Î²-Anomer of 9-(D-Arabinofuranosyl)adenine, J. Am. Chem. Soc. 1960, 82, 2648â2649.</span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text">Pizer, L. I.; Cohen, S. S. Abstr. 136th Meeting, Am. Chem. Soc., 1959, p. 9-C.</span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text">Duschinsky, R.; Pleven, E.; Malvica, J. Heidelberger, C. Abstr. 132nd Meeting, Am. Chem. Soc., 1957, p. 19-C.</span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text">Glaudemans, C. P. J.; Fletcher, Jr., H. G. Syntheses with Partially Benzylated Sugars. II. A Simple Pathway to a "Cisnucleoside," 9-Î²-D-Arabinofuranosyladenine (Spongoadenosine), J. Org. Chem., 1963, 28, 3004â3006; Reist, E. J.; Goodman, L. Synthesis of 9-Î²-D-Arabinofuranosylguanine, Biochemistry, 1964, 3, 15â18; Ikehara, M.; Ogiso, Y.  Studies of Nucleosides and Nucleotides. LIV. Purine Cyclonucleosides - 19. Further Investigation on the Cleavage of the 8,2'-O-Anhydro Linkage. A New Synthesis of 9-Î²-D-Arabinofuranosyl-adenine, Tetrahedron, 1972, 28, 3695â3704; Ranganathan, R. A Novel Purine Nucleoside Synthesis of 9-Î²-D-arabinofuranosyl-adenine, Tetrahedron Lett., 1975, 1185 - 1188; Sowa, T.; Tsunoda, K. Novel Synthesis of Anhydronucleosides via 2',3'-O-Sulfinate of Purine Nucleosides as Intermediates, Bull. Chem. Soc. Jpn., 1975, 48, 3243â3245; Chattopadhyaya. J.; Reese, C. B. Reaction of 8,2'-O-Cycloadenosine with Hydrazine and Amines. Convenient Preparation of 9-Î²-D-Arabinofuranosyladenine, J. Chem. Soc., Chem. Commun., 1977, 414â415; Ishido, Y.; Sakairi, N.; Okazaki, K.; Nakazaki, N. Partial Protection of Carbohydrate Derivatives. Part 4. Regioselective 2'-O-Deacylation of Fully Acylated Purine and Pyrimidine Ribonucleosides with Hydroxyaminium Acetate, J. Chem. Soc., Perk. Trans. 1, 1980, 563â573.</span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text">No inventor data available, Fermentation of 9-(Î²-D-Arabinofuranosyl)adenine, Brit. (1969) GB 1159290 1969â0723.</span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text">De Rudder, J.; Privat de Garlhe, M. Inhibitory Effect of Some Nucleosides on the Growth of Various Human Viruses in Tissue Culture, Antimicrobial Agents and Chemotherapy, 1965, 5, 578 - 584; Miller, F. A.; Dixon, G. J.; Ehrlich, J.; Sloan, B. J. McLean, Jr., I. W. Antiviral Activity of 9-Î²-D-Arabinofuranosyladenine. I. Cell Culture Studies, ibid.,  1968, 8, 136â147.</span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text">Komura, H.; Yoshino, T.; Ishido, Y. An Easy Method of Preparing Cyclic Carbonates of Polyhydroxy Compounds by Transesterification with Ethylene Carbonate, Bull. Chem. Soc. Jpn., 1973, 46, 550â553.</span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text">Utagawa, T.; Morisawa, H.; Miyoshi, T.; Yoshinaga, F.; Yamazaki, A.; Mitsusgi, K. A Novel and Simple Method for the Preparation of Adenine Arabinoside by Bacterial Transglycosylation Reactions, FEBS Lett., 1980, 109, 261 - 263; Yokozeki, K.; Yamanaka, F.; Utagawa, T.; Takinami, K.; Hirose, Y.,; Tanaka, A.; Sonomoto, K.; Fukui, S. Production of Adenine Arabinoside by Gel-Entrapped Cells of Enterobacter aerogenes in Water-Organic Cosolvent System, Eur. J. Microbiol. Biotechnol. 1982, 14, 225 - 231; Utagawa, T.; Morisawa, H.; Yamanaka, F.; Yamazaki, A.; Mitsugi, K.; Hirose, Y. Enzymatic Synthesis of Nucleoside Antibiotics. Part 1. Microbial Synthesis of Adenine Arabinoside, Agric. Biol. Chem., 1985, 49, 1053â1058,</span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text">Roshevskaia, L. A.; Barai, V. N.; Zinchenko, A. I.; Kvasiuk, E. I.; Mikhailopulo, L. A. Preparative Synthesis of the Antiviral Nucleoside 9-Î²-D-Arabinofuranosyladenine by Using Bacterial Cells, Antibiot. Med. Biotekhnol., 1986, 31, 174â178.</span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text">Caprioli, G; Colombo, P.; Farina, P.; Petricciani, L A process for the preparation of fludarabine phosphate from 2-fluroroadenine, EP1464708 A1, Oct. 6, 2004.</span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text">Drug Information Online - <a href="javascript:if(confirm('https://www.drugs.com/MMX/Vidarabine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/MMX/Vidarabine.html'" tppabs="https://www.drugs.com/MMX/Vidarabine.html" class="external free external">https://www.drugs.com/MMX/Vidarabine.html</a></span></li></ol></div>

<div role="navigation" class="navbox" aria-labelledby="DNA_virus_antivirals_(primarily_J05,_also_S01AD_and_D06BB)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="DNA_virus_antivirals_(primarily_J05,_also_S01AD_and_D06BB)" style="font-size:114%;margin:0 4em">DNA virus antivirals (primarily J05, also S01AD and D06BB)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Baltimore I</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Herpesvirus</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">DNA-synthesis<br>inhibitor</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">TK activated</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Purine analogue</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i><a href="Guanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Guanine" title="Guanine">guanine</a></i> (<a href="Aciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Aciclovir" title="Aciclovir">Aciclovir</a><sup>#</sup>/<a href="Valaciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Valaciclovir" title="Valaciclovir">Valaciclovir</a></li>
<li><a href="Ganciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ganciclovir" title="Ganciclovir">Ganciclovir</a>/<a href="Valganciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Valganciclovir" title="Valganciclovir">Valganciclovir</a><sup>#</sup></li>
<li><a href="Penciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Penciclovir" title="Penciclovir">Penciclovir</a>/<a href="Famciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Famciclovir" title="Famciclovir">Famciclovir</a>)</li></ul>

<ul><li><i><a href="Adenine.htm" tppabs="https://ptable.com/wiki/compounds/A/Adenine" title="Adenine">adenine</a></i> (<a href="Vidarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vidarabine" title="Vidarabine">Vidarabine</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Pyrimidine analogue</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i><a href="Uridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Uridine" title="Uridine">uridine</a></i> (<a href="Idoxuridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Idoxuridine" title="Idoxuridine">Idoxuridine</a></li>
<li><a href="Trifluridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trifluridine" title="Trifluridine">Trifluridine</a> (+tipiracil)</li>
<li><a href="Edoxudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Edoxudine" title="Edoxudine">Edoxudine</a>)</li></ul>

<ul><li><i><a href="Thymine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thymine" title="Thymine">thymine</a></i>
<ul><li>Brivudine</li>
<li>FV-100<sup>â </sup></li>
<li>Sorivudine</li></ul></li></ul>

<ul><li><i><a href="Cytosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cytosine" title="Cytosine">cytosine</a></i> (<a href="Cytarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cytarabine" title="Cytarabine">Cytarabine</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Not TK activated</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Foscarnet.htm" tppabs="https://ptable.com/wiki/compounds/A/Foscarnet" title="Foscarnet">Foscarnet</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Docosanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Docosanol" title="Docosanol">Docosanol</a></li>
<li>Maribavir<sup>â </sup></li>
<li><i>early protein</i> (Fomivirsen)</li>
<li>Tromantadine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">HPV/MC</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Imiquimod.htm" tppabs="https://ptable.com/wiki/compounds/A/Imiquimod" title="Imiquimod">Imiquimod</a>/Resiquimod</li>
<li><a href="Podophyllotoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Podophyllotoxin" title="Podophyllotoxin">Podophyllotoxin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Vaccinia</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>assembly:</i> <a href="Rifampicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifampicin" title="Rifampicin">Rifampicin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Poxviridae</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Methisazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methisazone" title="Methisazone" class="mw-redirect">Methisazone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Hepatitis B (VII)</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Nucleoside analogues/NARTIs:</i> <a href="Entecavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Entecavir" title="Entecavir">Entecavir</a><sup>#</sup></li>
<li><a href="Lamivudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamivudine" title="Lamivudine">Lamivudine</a></li>
<li>Lobucavir<sup>â </sup></li>
<li><a href="Telbivudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Telbivudine" title="Telbivudine">Telbivudine</a></li>
<li>Clevudine</li></ul>

<ul><li><i>Nucleotide analogues/NtRTIs:</i> <a href="Adefovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Adefovir" title="Adefovir">Adefovir</a></li>
<li>Tenofovir disoproxil</li>
<li>Tenofovir alafenamide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Multiple/general</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Nucleic acid inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cidofovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Cidofovir" title="Cidofovir">Cidofovir</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Interferon</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Interferon alfa 2b</li>
<li>Peginterferon alfa-2a</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Multiple/unknown</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Filociclovir<sup>â </sup></li>
<li><a href="Ribavirin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ribavirin" title="Ribavirin">Ribavirin</a><sup>#</sup>/Taribavirin<sup><b>â </b></sup></li>
<li>Moroxydine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>â¡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>â </sup>Phase III</li>
<li><sup>Â§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>




<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2018-02-10" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Vidarabine&oldid=824929833  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Vidarabine&oldid=824929833'" tppabs="https://en.wikipedia.org/wiki/?title=Vidarabine&oldid=824929833">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>